MeƱoza, Ann-jelly .
HRN: 23-75-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2023
CEFUROXIME 500MG (TAB)
09/30/2023
10/07/2023
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes